JPH1129500A - Fluorescent photodissociating protective group - Google Patents
Fluorescent photodissociating protective groupInfo
- Publication number
- JPH1129500A JPH1129500A JP9185167A JP18516797A JPH1129500A JP H1129500 A JPH1129500 A JP H1129500A JP 9185167 A JP9185167 A JP 9185167A JP 18516797 A JP18516797 A JP 18516797A JP H1129500 A JPH1129500 A JP H1129500A
- Authority
- JP
- Japan
- Prior art keywords
- group
- active substance
- proton
- amino
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Quinoline Compounds (AREA)
- Luminescent Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、新規な発蛍光性光
解離保護基に関する。[0001] The present invention relates to a novel fluorescent photolabile protecting group.
【0002】[0002]
【従来の技術】ある物質の生体における作用機構を調べ
るには、その物質の生体系内での消長を定量的に短時間
で測定をすることが必要であり、さらに系内に導入され
た該物質を追従する種々の変化を観察することも重要で
ある。2. Description of the Related Art In order to investigate the mechanism of action of a substance in a living body, it is necessary to quantitatively measure the fate of the substance in a biological system in a short time. It is also important to observe the various changes that follow the material.
【0003】一方生体反応は多くの場合極めて速く、ま
た複雑に関連した複数の反応が同時に進行することが普
通である。そのために外部から該物質を添加した場合
に、系内を拡散する過程がむしろ律速となり、実際測定
したいその後の反応が明確に捉らえられなくなってしま
うことが多い。その問題を解決するため、すばやく目的
物質を添加する方法について様々な方法が提案されてい
るが、現時点で必ずしも満足できるものはない。On the other hand, biological reactions are often extremely fast, and a plurality of complicatedly related reactions usually proceed simultaneously. Therefore, when the substance is added from the outside, the process of diffusing in the system becomes rather rate-determining, and the subsequent reaction to be actually measured often cannot be clearly grasped. In order to solve the problem, various methods for quickly adding the target substance have been proposed, but none of them is satisfactory at present.
【0004】その1つに、最近光照射に基づく技術が報
告されている。いわゆるケイジド(Caged)試薬、光ブロ
ック剤等として知られている保護基である。これらは一
般的には、追跡される生理活性物質の活性部位を該保護
基で保護(ブロック、またはケイジド化)したものを生
体系に導入し、十分該物質が作用点に拡散したことを確
認した後に、光照射に基づき、該保護基を脱保護基する
ものである。従って、遊離した生理活性を回復した物質
による反応が追跡可能となるものである。この保護基の
特徴は、光照射のみにより脱保護できる点であり、極め
て迅速に脱保護基可能であり、かつ必要ならば特定の部
分にのみ光照射をしぼり込むことも可能である点であ
る。ここで該保護基で保護される生理活性物質としては
種々の生体物質、例えばアミノ酸、タンパク質、酵素、
ヌクレオチド-3-リン酸、cAMP、核酸等が考えら
れ、いくつかの試みが種々検討されている。As one of them, a technique based on light irradiation has recently been reported. It is a protecting group known as a so-called Caged reagent, a light blocking agent and the like. In general, those in which the active site of a physiologically active substance to be tracked is protected (blocked or caded) with the protective group are introduced into a biological system, and it is confirmed that the substance has sufficiently diffused to the action point. After that, the protecting group is deprotected based on light irradiation. Therefore, it is possible to trace the reaction by the substance having recovered the released physiological activity. The feature of this protecting group is that it can be deprotected only by light irradiation, that it can be deprotected very quickly, and that it is possible to squeeze light irradiation only to a specific part if necessary. . Here, as the biologically active substance protected by the protecting group, various biological substances, for example, amino acids, proteins, enzymes,
Nucleotide-3-phosphate, cAMP, nucleic acid and the like are conceivable, and various attempts have been made.
【0005】しかしながら、上記の保護基で保護された
生理活性物質が、生体系で光照射により脱保護される反
応の定量性については、極めて重要であるにもかかわら
ず、いまだ確立された手段は報告されていない。[0005] However, although the quantification of the reaction in which the biologically active substance protected by the above-mentioned protecting group is deprotected by light irradiation in a biological system is extremely important, an established means has not yet been established. Not reported.
【発明が解決しようとする課題】本発明者は以上の点に
鑑み、鋭意研究し、生理活性物質の活性点を保護し、生
体系内の望ましい部位へ拡散された後、この保護基を光
を照射する方法で脱保護可能とする光解離保護基であっ
て、さらに、該保護基の脱保護反応を定量的に測定する
ことが可能となる新規な保護基(発蛍光性光解離保護
基)を見出すことに成功し本発明を完成するに至った。SUMMARY OF THE INVENTION In view of the above points, the present inventor has studied diligently to protect the active site of a physiologically active substance and, after being diffused to a desired site in a biological system, to apply this protective group to light. A photo-dissociable protecting group that can be deprotected by irradiating the compound with a protecting group (fluorescent photo-dissociating protecting group) capable of quantitatively measuring the deprotecting reaction of the protecting group. ) Was successfully found, and the present invention was completed.
【0006】[0006]
【課題を解決するための手段】すなわち、本発明に係る
保護基は、光照射により生理活性物質と切り放された後
に極めて強いカルボスチリル蛍光団に基づく蛍光性を発
現する化合物となるものである。この際、測定される該
カルボスチリル骨格に基づく蛍光の強度に基づき、脱保
護基化される生理活性物質の量を定量可能とするもので
ある。That is, the protecting group according to the present invention is a compound which expresses an extremely strong fluorescence based on the carbostyril fluorophore after being cleaved from the physiologically active substance by light irradiation. . At this time, the amount of the bioactive substance to be deprotected can be quantified based on the measured fluorescence intensity based on the carbostyril skeleton.
【0007】より詳しくは、本発明は、下記式1で示さ
れる保護基に関するものである。[0007] More specifically, the present invention relates to a protecting group represented by the following formula 1.
【0008】[0008]
【化1】 Embedded image
【0009】さらに、本発明は、上記保護基が、光反応
に基づく脱保護反応に基づき形成される下記式2で示さ
れるカルボスチリル誘導体の蛍光を測定することにより
検出する方法に係るものである。Further, the present invention relates to a method for detecting the above protecting group by measuring the fluorescence of a carbostyril derivative represented by the following formula 2, which is formed based on a deprotection reaction based on a photoreaction. .
【0010】[0010]
【化2】 Embedded image
【0011】さらに、本発明は、エチル (E) 3−
(2−アミノ−4、5−ジメトキシフェニル)−2−メ
チルプロペネイト、及び(E) 3−(2−アミノ−
4、5−ジメトキシフェニル)−2−メチルプロペン酸
を提供するものである。Further, the present invention provides an ethyl (E) 3-
(2-amino-4,5-dimethoxyphenyl) -2-methylpropenate and (E) 3- (2-amino-
4,5-dimethoxyphenyl) -2-methylpropenoic acid.
【0012】本発明に係る発蛍光性光解離保護基は、基
本的には上記のように、o-アミノケイ皮酸骨格を有す
るものであり、従って、エステル(チオエステルを含
む)結合、アミド(チオアミドを含む)結合等の結合に
基づき水酸基(フェノール性及びアルコール性水酸基を
含む)、チオール基、アミノ基を活性点とする生理活性
物質の保護基として広範囲に使用することができるもの
である。The fluorescent photodissociation protecting group according to the present invention basically has an o-aminocinnamic acid skeleton as described above, and therefore has an ester (including thioester) bond, an amide (thioamide) These compounds can be widely used as protecting groups for physiologically active substances having hydroxyl groups (including phenolic and alcoholic hydroxyl groups), thiol groups and amino groups as active sites based on bonds such as bonds.
【0013】[0013]
【化3】 Embedded image
【0014】ここでXはO、S(エステル、またはチオ
エステル等)、NHR(RはHまたはアルキル基等)で
ある。Here, X is O, S (ester or thioester, etc.) or NHR (R is H or alkyl group, etc.).
【0015】さらに、本発明に係る発蛍光性光解離保護
基は、光照射により、脱保護するものであるが、まず、
トランス配向している2重結合がシス異性化し、ベンゼ
ン環のアニリン性アミノ基と分子内アミド交換反応を起
こし、その結果、脱保護基化された生理活性物質及び、
カルボスチリル誘導体となるものと考えられる(図
1)。Furthermore, the fluorescent photo-dissociation protecting group according to the present invention is one that deprotects upon irradiation with light.
The trans-oriented double bond is cis-isomerized, causing an intramolecular transamidation reaction with the aniline amino group of the benzene ring, and as a result, a deprotected bioactive substance and
It is considered to be a carbostyril derivative (FIG. 1).
【0016】その結果生成するカルボスチリル誘導体は
強い蛍光を有する物質であり、通常の蛍光測定手段にて
定量可能である。The resulting carbostyril derivative is a substance having strong fluorescence and can be quantified by ordinary fluorescence measurement means.
【0017】[0017]
【発明の実施の形態】以下さらに詳しく本発明を説明す
る。BEST MODE FOR CARRYING OUT THE INVENTION The present invention will be described in more detail below.
【0018】合成方法 本発明に係るケイジド化合物の合成方法については特に
限定されず通常公知の有機化学反応が好ましく使用でき
る。具体的には、図2に例示されている合成ルートによ
るサリチルアルデヒド誘導体とWittig試薬との反応によ
るケイ皮酸骨格の形成、還元反応によるニトロ基のアミ
ノ基への変換によりトランス異性体のシンナメート誘導
体を得ることが可能である。 Synthesis Method The method for synthesizing the cadide compound according to the present invention is not particularly limited, and generally known organic chemical reactions can be preferably used. Specifically, a cinnamic acid skeleton is formed by reacting a salicylaldehyde derivative with a Wittig reagent according to the synthetic route illustrated in FIG. 2, and a trans isomer is converted into a nitro group into an amino group by a reduction reaction. It is possible to obtain
【0019】さらに、上記Wittig試薬との反応の後に加
水分解によるケイ皮酸誘導体へ変換し、その後、アミド
結合により適当な生理活性物質を縮合させ、その後還元
反応によりニトロ基をアミノ基へと変換することが可能
である。Further, after the reaction with the above Wittig reagent, the compound is converted into a cinnamic acid derivative by hydrolysis, and thereafter, an appropriate physiologically active substance is condensed by an amide bond, and then the nitro group is converted into an amino group by a reduction reaction. It is possible to
【0020】さらに、図2で例示した合成ルートによる
と、得られるシンナメートはアルキルエステル(例えば
エチルエステル)となっているが、このエステル結合
は、他の生理活性物質へのラベル化反応を行うには安定
すぎると考えられる。従って、該試薬を保存するにおい
ては便利であるが、上記ラベル化反応を行うにはさら
に、活性基を導入する必要がある。この目的で、従来使
用される活性基、例えば、カルボン酸基、酸ハロゲン化
物、酸無水物、活性エステル基、活性イミド基等が考え
られる。上記カルボン酸へは、通常の加水分解反応によ
り、容易に実施可能であり、カルボン酸が単離できる。
この得られるカルボン酸をさらに種々の活性基へと誘導
する事も通常の合成方法にて可能である。 具体的に
は、上記活性基としては、酸ハロゲン化物(臭素、塩
素、ヨウ素)、イミダゾリル基、スクシンイミド基、シ
アノ基、ブチロイル基、ビバロイル基等のアルキロイル
基、4−アミジノフェニルオキシ基、p−ニトロフェニ
ルオキシ基等のフェノキシ基である。Further, according to the synthetic route illustrated in FIG. 2, the obtained cinnamate is an alkyl ester (eg, ethyl ester), and this ester bond is necessary for performing a labeling reaction to another physiologically active substance. Is considered too stable. Therefore, it is convenient to store the reagent, but it is necessary to further introduce an active group in order to carry out the labeling reaction. For this purpose, conventionally used active groups such as carboxylic acid groups, acid halides, acid anhydrides, active ester groups, active imide groups and the like are conceivable. The above carboxylic acid can be easily carried out by a usual hydrolysis reaction, and the carboxylic acid can be isolated.
The resulting carboxylic acid can be further derivatized into various active groups by a usual synthesis method. Specifically, the active group includes acid halides (bromine, chlorine, iodine), imidazolyl group, succinimide group, cyano group, butyroyl group, alkyloyl group such as bivaloyl group, 4-amidinophenyloxy group, p-amido group and the like. It is a phenoxy group such as a nitrophenyloxy group.
【0021】これらの活性化基を有する本発明に係る保
護基と、種々の生理活性物質との反応により、生理活性
物質の保護化が可能となる。例えば、生理活性物質がア
ミノ酸、オリゴペプチド、蛋白質等であって、アミノ
基、フェノール性水酸基、チオール基、アルコール性水
酸基等がある場合には、アミド、エステル、またはチオ
アミド結合によりラベル化が可能となる。By reacting the protecting group according to the present invention having these activating groups with various physiologically active substances, the physiologically active substance can be protected. For example, when the physiologically active substance is an amino acid, an oligopeptide, a protein, or the like, and has an amino group, a phenolic hydroxyl group, a thiol group, an alcoholic hydroxyl group, and the like, it can be labeled with an amide, ester, or thioamide bond. Become.
【0022】ラベル化された生理活性物質の光反応によ
る脱保護基化 本発明に係る保護基を光照射により脱離し、カルボスチ
リル誘導体および、生理活性物質を遊離するための光反
応条件は、特に制限されず、通常の光源が使用可能であ
る。さらに必要な場合、顕微鏡下において、特定の時間
に細胞内の特定の位置に存在する該保護化生理活性物質
を部分的に遊離するために、該照射光を調整することも
可能である。By the photoreaction of the labeled physiologically active substance
That eliminated by light irradiation protecting group according to the deprotection ized present invention, the carbostyril derivatives and the light reaction conditions to release the bioactive substance is not particularly limited, conventional light sources can be used. If necessary, the irradiation light can be adjusted under a microscope to partially release the protected bioactive substance present at a specific position in a cell at a specific time.
【0023】保護された生理活性物質が、組織のどの場
所にあっても、顕微鏡等を使用する事でさらに特定の位
置でのみ脱保護反応を起こす事も可能である(図1)。Regardless of the location of the protected physiologically active substance in a tissue, it is possible to cause a deprotection reaction only at a specific position by using a microscope or the like (FIG. 1).
【0024】ケイジド試薬を使用した場合の生理活性物
質の発現量の定量 発現目的の生理活性物質を本発明に係る保護基として用
い、系内にて光照射を制御して目的の化合物(生理活性
物質)を発現させる量をも制御できる。 Physiologically active substance when a cadide reagent is used
Quantification of expression level of quality Using a physiologically active substance for expression purpose as a protecting group according to the present invention, the amount of expression of a target compound (bioactive substance) can be controlled by controlling light irradiation in the system.
【0025】図3に示されるように、本発明に係る保護
基を有するエチルエステル誘導体を、特定の光を照射す
ることにより、目的とするカルボスチリルによる発蛍光
現象が生じる事がわかる。As shown in FIG. 3, when the ethyl ester derivative having a protecting group according to the present invention is irradiated with a specific light, a desired fluorescent phenomenon by carbostyril occurs.
【0026】以下本発明を実施例に従いさらに詳しく説
明するが、本発明はこれらの実施例の限定されるもので
はない。Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.
【0027】[0027]
(エチルエステル誘導体の合成) (E)3−(3、4−ジメトキシ−6−ニトロフェニ
ル)−2−メチル−2−プロペン酸エチルエステル
(1)((E)3-(3,4-Dimethoxy-6-nitrophenyl-2-methyl
-2-propenic acid ethyl ester)の合成。(Synthesis of ethyl ester derivative) (E) 3- (3,4-dimethoxy-6-nitrophenyl) -2-methyl-2-propenoic acid ethyl ester (1) ((E) 3- (3,4-Dimethoxy) -6-nitrophenyl-2-methyl
Synthesis of 2-propenic acid ethyl ester).
【0028】6−ニトロベラトラルアルデヒド10g(6-N
itoroveratlaldehyde,アルドリッチ社製)を、Wittig試
薬(carboethoxy ethylidene triphenylphosphorane,ア
ルドリッチ社製)18.1g(50mmol)とを、ベンゼン中、室
温で、約18時間撹拌して反応させた。この際反応は暗室
にて行った。反応終了後、減圧でベンゼンを除き、白色
結晶を得た。これを酢酸エチルから再結晶して目的化合
物(1)が28.5g得られた(収率76%)。10 g of 6-nitroveratraldehyde (6-N
Itoroveratlaldehyde (Aldrich) and 18.1 g (50 mmol) of Wittig reagent (carboethoxy ethylidene triphenylphosphorane, Aldrich) were reacted by stirring in benzene at room temperature for about 18 hours. At this time, the reaction was performed in a dark room. After completion of the reaction, benzene was removed under reduced pressure to obtain white crystals. This was recrystallized from ethyl acetate to obtain 28.5 g of the target compound (1) (yield: 76%).
【0029】本化合物の構造は赤外線吸収スペクトル
(IR)、1H−NMR、TOF−MSにより確認し
た。IR:1700cm-1(エステル)。TOF−MS:296
(M/C)。1H−NMR(クロロホルム、δppm):7.92(s,
1H,芳香環又は二重結合のメチン基プロトン)、7.74(s,
1H,芳香環又は二重結合のメチン基プロトン)、6.72(s,
1H,芳香環又は二重結合のメチン基プロトン)、4.29(q,
2H,エチル基のメチレン基プロトン)、3.99(s,3H,メト
キシ基のメチル基プロトン)、3.96(s,3H,メトキシ基の
メチル基プロトン)、3.57(s,2H,アニリンのアミノ基プ
ロトン)、1.92(s,3H,2位メチル基プロトン)、1.36
(t,3H,エチル基のメチル基プロトン)。The structure of the compound was confirmed by infrared absorption spectrum (IR), 1 H-NMR and TOF-MS. IR: 1700 cm -1 (ester). TOF-MS: 296
(M / C). 1 H-NMR (chloroform, δ ppm): 7.92 (s,
1H, methine group proton of aromatic ring or double bond), 7.74 (s,
1H, methine group proton of aromatic ring or double bond), 6.72 (s,
1H, aromatic ring or double bond methine group proton), 4.29 (q,
2H, methylene proton of ethyl group), 3.99 (methyl proton of s, 3H, methoxy group), 3.96 (methyl proton of s, 3H, methoxy group), 3.57 (amino proton of s, 2H, aniline) , 1.92 (s, 3H, 2-position methyl group proton), 1.36
(t, 3H, methyl group proton of ethyl group).
【0030】(E)3−(2−アミノ−4、5−ジメト
キシフェニル)−2−メチル−2−プロペン酸エチルエ
ステル((E)3-(2-Amino-4,5-Dimethoxyphenyl-2-methyl
-2-propenic acid ethyl ester)の合成。(E) Ethyl 3- (2-amino-4,5-dimethoxyphenyl) -2-methyl-2-propenoate ((E) 3- (2-Amino-4,5-Dimethoxyphenyl-2-) methyl
Synthesis of 2-propenic acid ethyl ester).
【0031】上記で得られた(1)19.0gを、氷酢酸250ml
に溶解し、これに鉄粉末15.0gとイオン交換水20mlを加
え、40分間、加熱環流した。後、反応溶液を濾過して鉄
粉末を除き、得られた濾液を減圧にて濃縮し、残留物を
酢酸エチルに溶解した後、水、5%重曹水、飽和塩化ナ
トリウム水溶液にて順次酢酸エチル層を洗浄し、無水硫
酸ナトリウム上で一晩乾燥させた。酢酸エチルを減圧で
除き、残渣をヘキサン/エタノールから再結晶して目的
物を12.5g得た(収率78%)。19.0 g of (1) obtained above was mixed with 250 ml of glacial acetic acid.
And 15.0 g of iron powder and 20 ml of ion-exchanged water were added thereto, and the mixture was heated under reflux for 40 minutes. Thereafter, the reaction solution was filtered to remove iron powder, the obtained filtrate was concentrated under reduced pressure, the residue was dissolved in ethyl acetate, and then ethyl acetate was successively added with water, 5% aqueous sodium bicarbonate, and a saturated aqueous sodium chloride solution. The layer was washed and dried over anhydrous sodium sulfate overnight. Ethyl acetate was removed under reduced pressure, and the residue was recrystallized from hexane / ethanol to obtain 12.5 g of the desired product (78% yield).
【0032】本化合物の構造は赤外線吸収スペクトル
(IR)、1H−NMR、TOF−MSにより決定し
た。IR:1689cm-1(エステル)。TOF−MS:265
(M/C)。1H−NMR(クロロホルム、δ):7.57(s,1H,
芳香環又は二重結合のメチン基プロトン), 6.68(s,1H,
芳香環又は二重結合のメチン基プロトン), 6.29(s,1H,
芳香環又は二重結合のメチン基プロトン), 4.25(q,2H,
エチル基のメチレン基プロトン), 3.84(s,3H,メトキシ
基のメチル基プロトン), 3.79(s,3H,メトキシ基のメチ
ル基プロトン), 3.57(s,2H,アニリンのアミノ基プロト
ン), 2.03(s,3H,2位メチル基プロトン), 1.33(t,3H,
エチル基のメチル基プロトン) (フェネチルアミド誘導体の合成) (E)3−(3、4−ジメトキシ−6−ニトロフェニ
ル)−2−メチル−2−プロペン酸((E)3-(3,4-Dimeth
oxy-6-nitrophenyl-2-methyl-2-propenic acid)の合
成。The structure of the compound was determined by infrared absorption spectrum (IR), 1 H-NMR, and TOF-MS. IR: 1689 cm -1 (ester). TOF-MS: 265
(M / C). 1 H-NMR (chloroform, δ): 7.57 (s, 1H,
Methine group proton of an aromatic ring or a double bond), 6.68 (s, 1H,
Methine group proton of an aromatic ring or a double bond), 6.29 (s, 1H,
Methine group proton of aromatic ring or double bond), 4.25 (q, 2H,
Methylene group proton of ethyl group), 3.84 (methyl proton of s, 3H, methoxy group), 3.79 (methyl proton of s, 3H, methoxy group), 3.57 (s, 2H, amino proton of aniline), 2.03 (s, 3H, 2-position methyl group proton), 1.33 (t, 3H,
(Ethyl methyl proton) (Synthesis of phenethylamide derivative) (E) 3- (3,4-dimethoxy-6-nitrophenyl) -2-methyl-2-propenoic acid ((E) 3- (3,4 -Dimeth
Synthesis of oxy-6-nitrophenyl-2-methyl-2-propenic acid).
【0033】上記得られた(E)3−(3、4−ジメト
キシ−6−ニトロフェニル)−2−メチル−2−プロペ
ン酸エチルエステル(1)11.3gをメタノール250mlに溶
解し、これに2規定水酸化ナトリウム水溶液45mlを加え
て、40℃にて4時間反応させた。反応終了後、1規定塩
酸を用いて溶液をpH4に調整した後、冷却し、析出した
結晶を濾過して分離し、目的化合物10.1gを得た(収率9
9%)。The above-obtained (E) 3- (3,4-dimethoxy-6-nitrophenyl) -2-methyl-2-propenoic acid ethyl ester (1) (11.3 g) was dissolved in methanol (250 ml). 45 ml of a normal aqueous sodium hydroxide solution was added, and the mixture was reacted at 40 ° C. for 4 hours. After completion of the reaction, the solution was adjusted to pH 4 using 1 N hydrochloric acid, cooled, and the precipitated crystals were separated by filtration to obtain 10.1 g of the target compound (yield 9).
9%).
【0034】本化合物の構造は赤外線吸収スペクトル
(IR)、1H−NMR、TOF−MSにより決定し
た。IR:1685cm-1(カルボキシル基)。TOF−M
S:268(M/C)。1H−NMR(重DMSO、δppm):7.76
(s,1H,芳香環又は二重結合のメチン基プロトン), 7.72
(s,1H,芳香環又は二重結合のメチン基プロトン), 6.97
(s,1H,芳香環又は二重結合のメチン基プロトン), 3.90
(s,6H,メトキシ基のメチル基プロトン), 3.57(s,2H,ア
ニリンのアミノ基プロトン), 1.84(s,3H,2位メチル基
プロトン)。The structure of the compound was determined by infrared absorption spectrum (IR), 1 H-NMR, and TOF-MS. IR: 1685 cm -1 (carboxyl group). TOF-M
S: 268 (M / C). 1 H-NMR (heavy DMSO, δppm): 7.76
(s, 1H, aromatic ring or double bond methine group proton), 7.72
(s, 1H, methine group proton of aromatic ring or double bond), 6.97
(s, 1H, methine group proton of aromatic ring or double bond), 3.90
(s, 6H, methyl group proton of methoxy group), 3.57 (s, 2H, amino group proton of aniline), 1.84 (s, 3H, 2-position methyl group proton).
【0035】(E)3−(3、4−ジメトキシ−6−ニ
トロフェニル)−2−メチル−2−プロペン酸フェネチ
ルアミド((E)3-(3,4-Dimethoxy-6-nitorphenyl-2-meth
yl-2-propenic acid phenethylamide)の合成。(E) 3- (3,4-Dimethoxy-6-nitrophenyl) -2-methyl-2-propenoic acid phenethylamide ((E) 3- (3,4-Dimethoxy-6-nitorphenyl-2- meth
Synthesis of yl-2-propenic acid phenethylamide).
【0036】上記得られた(E)3−(3、4−ジメト
キシ−6−ニトロフェニル)−2−メチル−2−プロペ
ン酸と2−フェネチルアミン(東京化成(株)製)と
を、ジクロロメタン100mlに溶解し、0℃に冷却した後、
EDC-HCl(1-(3-Dimethylaminopropyl)-3-ethylcarbodii
mide hydrochloride,アルドリッチ社製)を10.2g添加し
て一晩撹拌して反応させた。溶媒を減圧で除き、残渣に
酢酸エチル及び水を加えた。有機溶媒層を洗浄後、無視
硫酸ナトリウムで乾燥した。溶媒を減圧で除き、得られ
た残渣をシリカゲルクロマトグラフ(展開溶媒:クロロ
ホルム/メタノール=50/1)にて目的化合物を14.1g得た
(収率定量的)。The obtained (E) 3- (3,4-dimethoxy-6-nitrophenyl) -2-methyl-2-propenoic acid and 2-phenethylamine (manufactured by Tokyo Chemical Industry Co., Ltd.) were mixed with 100 ml of dichloromethane. And cooled to 0 ° C,
EDC-HCl (1- (3-Dimethylaminopropyl) -3-ethylcarbodii
mide hydrochloride (manufactured by Aldrich) was added and stirred overnight to react. The solvent was removed under reduced pressure, and ethyl acetate and water were added to the residue. After washing the organic solvent layer, it was dried over sodium sulfate. The solvent was removed under reduced pressure, and the resulting residue was subjected to silica gel chromatography (developing solvent: chloroform / methanol = 50/1) to obtain 14.1 g of the target compound (quantitative yield).
【0037】本化合物の構造は赤外線吸収スペクトル
(IR)、1H−NMR、TOF−MSにより決定し
た。IR:3280, 1627cm-1(アミド基)。TOF−M
S:370(M/C)。1H−NMR(クロロホルム、δppm):
7.73-7.22(m,7H,芳香族プロトン又は二重結合プロト
ン)、6.70(s,1H,芳香族プロトン又は二重結合プロト
ン)、6.01(s,1H,アミド結合NH)、3.97(s,3H,メトキシ
基のメチル基プロトン)、3.94(s,3H,メトキシ基のメチ
ル基プロトン)、3.63(dt,2H,フェネチル基の1'位メチ
レン基プロトン)、2.91(t,2H,フェネチル基の2'位メチ
レン基プロトン)、1.86(s,3H,メチル基プロトン)。The structure of the compound was determined by infrared absorption spectrum (IR), 1 H-NMR, and TOF-MS. IR: 3280, 1627 cm -1 (amide group). TOF-M
S: 370 (M / C). 1 H-NMR (chloroform, δ ppm):
7.73-7.22 (m, 7H, aromatic proton or double bond proton), 6.70 (s, 1H, aromatic proton or double bond proton), 6.01 (s, 1H, amide bond NH), 3.97 (s, 3H , Methoxy group methyl group proton), 3.94 (s, 3H, methoxy group methyl group proton), 3.63 (dt, 2H, phenethyl group 1 'methylene group proton), 2.91 (t, 2H, phenethyl group 2 'Position methylene group proton), 1.86 (s, 3H, methyl group proton).
【0038】(E)3−(2−アミノ4、5−ジメトキ
シフェニル)−2−メチル−2−プロペン酸フェネチル
アミド((E)3-(2-Amino-4,5-Dimethoxyphenyl)-2-meth
yl-2-propionic acid Phenethyl amide)の合成。(E) 3- (2-Amino-4,5-dimethoxyphenyl) -2-methyl-2-propenoic acid phenethylamide ((E) 3- (2-Amino-4,5-Dimethoxyphenyl) -2- meth
Synthesis of yl-2-propionic acid Phenethyl amide).
【0039】上記得られた(E)3−(3、4−ジメト
キシ−6−ニトロフェニル)−2−メチル−2−プロペ
ン酸フェネチルアミド14.1gを氷酢酸164mlに溶解し、こ
れに鉄粉末9.8gとイオン交換水13mlを加え、加熱環流を
40分おこない反応させた。後、反応液を濾過して鉄粉末
を除き、濾液を減圧で濃縮して得られた残留物を酢酸エ
チルに溶解し、水、5%重曹水、飽和塩化ナトリウム水
溶液にて順次酢酸エチル層を洗浄し、無水硫酸ナトリウ
ム上で一晩乾燥させた。酢酸エチルを減圧で除き、残渣
をヘキサン/エタノールから再結晶して目的物を8.9g得
た(収率69%)。The above-obtained (E) 3- (3,4-dimethoxy-6-nitrophenyl) -2-methyl-2-propenoic acid phenethylamide (14.1 g) was dissolved in glacial acetic acid (164 ml), and iron powder 9.8 was added thereto. g and 13 ml of ion-exchanged water.
The reaction was carried out for 40 minutes. Thereafter, the reaction solution was filtered to remove iron powder, the filtrate was concentrated under reduced pressure, and the obtained residue was dissolved in ethyl acetate. The ethyl acetate layer was successively separated with water, 5% aqueous sodium hydrogen carbonate and saturated aqueous sodium chloride. Washed and dried over anhydrous sodium sulfate overnight. The ethyl acetate was removed under reduced pressure, and the residue was recrystallized from hexane / ethanol to obtain 8.9 g of the desired product (69% yield).
【0040】本化合物の構造は赤外線吸収スペクトル
(IR)、1H−NMR、TOF−MSにより決定し
た。IR:3326, 3207, 1602cm-1(アミド基)。TOF
−MS:340(M/C)。1H−NMR(クロロホルム、
δ):7.35〜7.21(m,6H,芳香環プロトン), 6.60(s,1H,
芳香環プロトン), 5.93(s,1H,アミドプロトン), 3.84
(s,3H,メトキシ基のメチル基プロトン), 3.78(s,3H,メ
トキシ基のメチル基プロトン),3.64(dt,2H,フェネチル
基の1'位メチレン基プロトン), 3.54(s,2H,アニリン基
のアミノプロトン), 2.90(t,2H,フェネチル基の2'位メ
チレン基プロトン), 1.96(s,3H,2位メチル基プロト
ン)。The structure of this compound was determined by infrared absorption spectrum (IR), 1 H-NMR, and TOF-MS. IR: 3326, 3207, 1602 cm -1 (amide group). TOF
-MS: 340 (M / C). 1 H-NMR (chloroform,
δ): 7.35 to 7.21 (m, 6H, aromatic ring proton), 6.60 (s, 1H,
Aromatic ring proton), 5.93 (s, 1H, amide proton), 3.84
(s, 3H, methoxy group methyl proton), 3.78 (s, 3H, methoxy methyl proton), 3.64 (dt, 2H, 1 'methylene proton of phenethyl group), 3.54 (s, 2H, Aniline group amino proton), 2.90 (t, 2H, phenethyl group 2'-position methylene group proton), 1.96 (s, 3H, 2-position methyl group proton).
【0041】(蛍光性カルボスチリル誘導体の合成)
6、7−ジメトキシ−3−メチルカルボスチリル(6,7-D
imethoxy-3-methylcarbostyril) (E)3−(3、4−ジメトキシ−6−ニトロフェニ
ル)−2−メチル−2−プロペン酸エチルエステル
(1)0.5gをエチルアルコール30mlに溶解し、これに36
5nmの紫外線を約20時間照射し、析出した結晶を濾過し
て分離し、さらに得られた結晶をエタノールから再結晶
し目的化合物0.38gを得た(収率92.1%)。(Synthesis of Fluorescent Carbostyril Derivative)
6,7-dimethoxy-3-methylcarbostyril (6,7-D
imethoxy-3-methylcarbostyril) (E) Dissolve 0.5 g of 3- (3,4-dimethoxy-6-nitrophenyl) -2-methyl-2-propenoic acid ethyl ester (1) in 30 ml of ethyl alcohol, and add 36 g of
Ultraviolet rays of 5 nm were irradiated for about 20 hours, the precipitated crystals were separated by filtration, and the obtained crystals were recrystallized from ethanol to obtain 0.38 g of the target compound (yield 92.1%).
【0042】本化合物の構造は赤外線吸収スペクトル
(IR)、1H−NMR、TOF−MSにより決定し
た。IR:1654cm-1(ラクタム)。TOF−MS:219
(M/C)。1H−NMR(クロロホルム、δ):12.3(s,1H,
アミドプロトン),7.56(s,1H,4位プロトン),6.90(s,1
H,5位あるいは8位プロトン),6.88(s,1H,5位あるい
は8位プロトン), 3.99(s,3H,メトキシ基のメチル),
3.92(s,3H,メトキシ基のメチル), 2.28(s,3H,3位メチ
ル)。The structure of the compound was determined by infrared absorption spectrum (IR), 1 H-NMR, and TOF-MS. IR: 1654 cm -1 (lactam). TOF-MS: 219
(M / C). 1 H-NMR (chloroform, δ): 12.3 (s, 1H,
Amide proton), 7.56 (s, 1H, 4-position proton), 6.90 (s, 1
H, 5th or 8th proton), 6.88 (s, 1H, 5th or 8th proton), 3.99 (s, 3H, methyl of methoxy group),
3.92 (s, 3H, methyl of methoxy group), 2.28 (s, 3H, 3-position methyl).
【0043】(光照射による脱保護基化反応)(E)3
−(3、4−ジメトキシ−6−ニトロフェニル)−2−
メチル−2−プロペン酸エチルエステル(1)を含む溶
液の光照射により脱保護基化反応をHPLCによりモニ
ター(340nm)した。(Deprotection grouping reaction by light irradiation) (E) 3
-(3,4-dimethoxy-6-nitrophenyl) -2-
The solution containing methyl-2-propenoic acid ethyl ester (1) was irradiated with light to monitor the deprotection reaction by HPLC (340 nm).
【0044】HPLC条件:カラム、ODSφ4.6mmx150mm
(SHISEIDO CacellPakC18);移動層、アセトニトリル/
水=30/70から60/40へ(0分から20分)流速1.0ml/分。HPLC conditions: column, ODS φ4.6 mm × 150 mm
(SHISEIDO CacellPakC18); moving bed, acetonitrile /
Water = 30/70 to 60/40 (0 to 20 minutes) with a flow rate of 1.0 ml / min.
【0045】光照射前は、保持時間7.7分に上記化合物
のピークが観測された。光照射により保持時間3.7分に
新しいピークが観測された。この3.7分のピークは、カ
ルボスチリルのピークと一致した。Before light irradiation, a peak of the above compound was observed at a retention time of 7.7 minutes. A new peak was observed at a retention time of 3.7 minutes by light irradiation. This 3.7 minute peak coincided with the carbostyril peak.
【0046】同様に(E)3−(2−アミノ4、5−ジ
メトキシフェニル)−2−メチル−2−プロペン酸フェ
ネチルアミドを含む溶液の光照射により脱保護基化反応
をHPLCによりモニター(260nm)した。Similarly, a solution containing (E) 3- (2-amino-4,5-dimethoxyphenyl) -2-methyl-2-propenoic acid phenethylamide was irradiated with light to monitor the deprotection reaction by HPLC (260 nm). )did.
【0047】HPLC条件:カラム、ODSφ4.6mmx150mm
(SHISEIDO CacellPakC18);移動層、アセトニトリル/
水=30/70から60/40へ(0分から20分)流速1.0ml/分。HPLC conditions: column, ODS φ4.6 mm × 150 mm
(SHISEIDO CacellPakC18); moving bed, acetonitrile /
Water = 30/70 to 60/40 (0 to 20 minutes) with a flow rate of 1.0 ml / min.
【0048】光照射前は、保持時間6.9分に上記フェネ
チルアミド化合物のピークが観測された。光照射により
保持時間3.8分に新しいピークが観測された。この3.8分
のピークは、カルボスチリルのピークと一致した。Before the light irradiation, the peak of the phenethylamide compound was observed at a retention time of 6.9 minutes. A new peak was observed at a retention time of 3.8 minutes by light irradiation. This peak at 3.8 minutes coincided with the peak of carbostyril.
【0049】さらに、以下のHPLC条件で(E)3−
(2−アミノ4、5−ジメトキシフェニル)−2−メチ
ル−2−プロペン酸フェネチルアミドを含む溶液の光照
射により脱保護基化反応をモニター(260nm)した。Further, (E) 3-
The deprotection reaction was monitored (260 nm) by irradiating the solution containing (2-amino-4,5-dimethoxyphenyl) -2-methyl-2-propenoic acid phenethylamide with light.
【0050】HPLC条件:カラム、ODSφ4.6mmx150mm
(SHISEIDO CacellPakC18);移動層、アセトニトリル/
水=20/80から60/40へ(5分から20分)流速1.0ml/分。HPLC conditions: column, ODS φ4.6 mm × 150 mm
(SHISEIDO CacellPakC18); moving bed, acetonitrile /
Water = 20/80 to 60/40 (5 to 20 minutes) at a flow rate of 1.0 ml / min.
【0051】光照射前は、保持時間19.2分に上記フェネ
チルアミド化合物のピークが観測された。光照射により
保持時間10.0分と、6.6分に新しいピークが観測され
た。この10.0分のピークは、カルボスチリルのピークと
一致し、6.6分のピークはフェネチルアミンのピークと
一致した。Before the light irradiation, the peak of the phenethylamide compound was observed at a retention time of 19.2 minutes. New peaks were observed at the retention time of 10.0 minutes and 6.6 minutes by light irradiation. The peak at 10.0 minutes coincided with the peak of carbostyril, and the peak at 6.6 minutes coincided with the peak of phenethylamine.
【図1】本発明に係る保護基を用いて保護された生理活
性物質に光照射することにより、脱保護基化され、生理
活性物質を遊離することを示す図である。FIG. 1 is a diagram showing that a biologically active substance protected using a protecting group according to the present invention is deprotected by light irradiation to release a biologically active substance.
【図2】本発明に係る保護基により保護された生理活性
物質の調整方法を示す図である。FIG. 2 is a diagram illustrating a method for preparing a physiologically active substance protected by a protecting group according to the present invention.
【図3】(E)3−(3、4−ジメトキシ−6−ニトロ
フェニル)−2−メチル−2−プロペン酸エチルエステ
ルを含む溶液の光照射による脱保護基化反応を示す図で
ある。FIG. 3 (E) is a diagram showing a deprotection grouping reaction of a solution containing 3- (3,4-dimethoxy-6-nitrophenyl) -2-methyl-2-propenoic acid ethyl ester by light irradiation.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI // C07D 215/22 C07D 215/22 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 6 Identification code FI // C07D 215/22 C07D 215/22
Claims (4)
−アミノ−4、5−ジメトキシフェニル)−2−メチル
アクリロイル基を有する新規発蛍光性光解離保護基。 【化1】 (E) 3- (2) represented by the following formula 1.
-Amino-4,5-dimethoxyphenyl) -2-methylacryloyl group having a novel fluorescent photolabile protecting group. Embedded image
く脱保護反応を、形成される下記式2で示されるカルボ
スチリル誘導体の蛍光を測定することにより検出する方
法。 【化2】 2. A method for detecting a deprotection reaction based on a photoreaction of a protecting group according to claim 1 by measuring fluorescence of a carbostyril derivative represented by the following formula 2 to be formed. Embedded image
4、5−ジメトキシフェニル)−2−メチルプロペネイ
ト。3. Ethyl (E) 3- (2-amino-
4,5-Dimethoxyphenyl) -2-methylpropenate.
メトキシフェニル)−2−メチルプロペン酸。(E) 3- (2-amino-4,5-dimethoxyphenyl) -2-methylpropenoic acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9185167A JPH1129500A (en) | 1997-07-10 | 1997-07-10 | Fluorescent photodissociating protective group |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9185167A JPH1129500A (en) | 1997-07-10 | 1997-07-10 | Fluorescent photodissociating protective group |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH1129500A true JPH1129500A (en) | 1999-02-02 |
Family
ID=16166013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9185167A Pending JPH1129500A (en) | 1997-07-10 | 1997-07-10 | Fluorescent photodissociating protective group |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH1129500A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6229020B1 (en) | 1999-01-12 | 2001-05-08 | Laboratory Of Molecular Biophotonics | Reagents for preparation of caged compounds, and method for preparation of the caged compounds |
US6329546B1 (en) | 1999-01-12 | 2001-12-11 | Laboratory Of Molecular Biophotonics | Caged amino acids |
WO2009113322A1 (en) * | 2008-03-11 | 2009-09-17 | 国立大学法人奈良先端科学技術大学院大学 | Photodissociable protective group |
CN104316514A (en) * | 2014-11-07 | 2015-01-28 | 中国科学技术大学 | Dual-functionalized graphene oxide composite material as well as preparation method and application thereof |
CN108530483A (en) * | 2018-01-15 | 2018-09-14 | 四川大学 | Wittig reagents based on coumarin skeleton and its preparation method and application |
-
1997
- 1997-07-10 JP JP9185167A patent/JPH1129500A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6229020B1 (en) | 1999-01-12 | 2001-05-08 | Laboratory Of Molecular Biophotonics | Reagents for preparation of caged compounds, and method for preparation of the caged compounds |
US6329546B1 (en) | 1999-01-12 | 2001-12-11 | Laboratory Of Molecular Biophotonics | Caged amino acids |
WO2009113322A1 (en) * | 2008-03-11 | 2009-09-17 | 国立大学法人奈良先端科学技術大学院大学 | Photodissociable protective group |
US8222429B2 (en) | 2008-03-11 | 2012-07-17 | National University Corporation NARA Institute of Science and Technology | Photodissociable protective group |
CN104316514A (en) * | 2014-11-07 | 2015-01-28 | 中国科学技术大学 | Dual-functionalized graphene oxide composite material as well as preparation method and application thereof |
CN108530483A (en) * | 2018-01-15 | 2018-09-14 | 四川大学 | Wittig reagents based on coumarin skeleton and its preparation method and application |
CN108530483B (en) * | 2018-01-15 | 2020-07-28 | 四川大学 | Wittig reagent based on coumarin skeleton and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4899046B2 (en) | New luciferin derivatives | |
EP0268190B1 (en) | Prolinal derivatives | |
CN110283583B (en) | Gamma-glutamyl transpeptidase responsive molecular probe and application thereof | |
US4237047A (en) | Peptide derivative | |
JP2691442B2 (en) | Novel proline derivative | |
Russell et al. | Photorelease of tyrosine from a-carboxy-6-nitroveratryl (aCNV) derivatives | |
Seki et al. | A practical synthesis of (+)‐biotin from L‐cysteine | |
JPH1129500A (en) | Fluorescent photodissociating protective group | |
Labroo et al. | An improved synthesis of dioxindole-3-propionic acid and some transformations of the C-3 hydroxyl group | |
WO2001044228A2 (en) | Derivatives of quinazolinedione phthalimide, preparations thereof and their therapeutic uses | |
JP4251892B2 (en) | Method for esterifying 4-guanidinobenzoic acid or its derivatives | |
Morera et al. | An improved preparation of 4-hydroxymethyl-L-phenylalanine | |
BE1008216A4 (en) | HETEROCYCLIC CHEMOLUMINESCENT DERIVATIVES. | |
US3467690A (en) | 3,5-dimethoxybenzyl carbonate esters | |
Murashige et al. | Effective synthesis of optically active trifluoromethyldiazirinyl homophenylalanine and aroylalanine derivatives with the Friedel-Crafts reaction in triflic acid | |
JPH09227560A (en) | Photo-dissociable fluorescent-protecting group | |
WO1998011057A1 (en) | Optically active erythro-3-amino-2-hydroxybutyric esters and process for preparing said esters | |
Kessler et al. | 4-diazocyclohexa-2, 5-dienones as photoaffinity reagents for proteins | |
JPH0557265B2 (en) | ||
Lau et al. | Synthesis of penicillin N and isopenicillin N | |
JP2873040B2 (en) | Derivatization reagent for high-performance liquid chromatography | |
Rajappan et al. | Pentafluorophenol: A superior reagent for condensations in heterocyclic chemistry | |
CN113354608A (en) | Photoactivation fluorescent probe and preparation method and application thereof | |
JPS626560B2 (en) | ||
JPS6027675B2 (en) | 7-Arginylamino-4-methylcoumarin |